The Latest Breaking News on Diabetes

Experts Warn: 1 in 10,000 Wegovy Users Face 5X Higher Risk Leading to Serious Eye Complications

Experts warn that 1 in 10,000 Wegovy users face a fivefold higher risk of serious eye complications, including permanent vision loss, compared to Ozempic.

International Business Times UK · Mar 11

Patients alarmed after glucose monitors used by diabetics are recalled after links to 7 deaths

Abbott recalled certain sensors used in its FreeStyle Libre 3 and FreeStyle Libre 3 Plus systems, warning they could produce falsely low glucose readings

The Independent UK · Mar 11

Weight loss jab ‘may carry higher risk of sudden sight loss’ as new warning issued

Wegovy is approved on the NHS to help people lose weight in higher doses

The Independent UK · Mar 10

Weight-loss drugs alone will not solve UK’s obesity crisis, says Chris Whitty

Chief medical adviser warns of side-effects and calls for action on junk food advertising and making food healthier

The Guardian - UK · Mar 6

Other countries are streets ahead of the UK on childhood obesity. Here’s what they’re doing differently

There could be 227 million obese children worldwide by 2040. But as South Korea and Denmark have shown, it is possible to tackle this crisis, says Devi Sridhar, chair of global public health at the University of Edinburgh

The Guardian - UK · Mar 6

Weight-loss jab could be made for $3 a month, study finds

Cheap semaglutide, the drug in Ozempic and Wegovy, could help millions with diabetes and obesity in 160 countries

The Guardian - UK · Mar 6

Oprah Winfrey's Stunning Look at 72: Her Paris Fashion Week Moment and GLP-1 Weight Loss Journey

Oprah Winfrey's 50-pound weight loss at 72 using GLP-1 drugs raises questions about affordability and accessibility. Explore her journey and its impact on WeightWatchers and the fashion world.

International Business Times UK · Mar 6

GLP-1s could help curb substance abuse – including alcohol and opioids, new study finds

Increasingly popular GLP-1 drugs used to treat diabetes and obesity show promise in fighting multiple substance use disorders

The Independent UK · Mar 4

Weight loss drugs may stop people getting addicted to drugs and alcohol, study finds

US study suggests GLP-1s, used to treat type 2 diabetes, could also reduce risk of people already using substances from overdosing

The Guardian - UK · Mar 4

Stopping weight loss jabs could leave users ‘worse off than before’

GLP-1 users likely to regain two-thirds of the weight they lost within a year, study shows

The Independent UK · Mar 4